We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

3 hedge funds and large institutions have $907K invested in AYTU BioPharma in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.4% more ownership

Funds ownership: 0% → 1.4% (+1.4%)

Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Armistice Capital
Armistice Capital
New York
+$1.1M
2
Bard Associates
Bard Associates
Illinois
+$95.5K
3
Hartford Financial Management
Hartford Financial Management
Connecticut
+$23.9K

Top Sellers

No sellers this quarter

AYTU Hedge Fund Activity: Q4 2017 in Review

3 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2017, worth a combined $907K.

Buyers outnumbered sellers: 3 funds opened new AYTU positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.1M.

  • 3 institutional investors held AYTU BioPharma (AYTU) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $907K of AYTU BioPharma stock for Q4 2017.
  • 3 funds opened new AYTU BioPharma positions in Q4 2017 and 0 closed out, a net change of +3 holders.
  • The largest AYTU BioPharma buyer in Q4 2017 was Armistice Capital, an estimated $1.1M added.

Based on aggregated 13F filings for Q4 2017.